• Je něco špatně v tomto záznamu ?

Non-small Cell Lung Cancer as a Chronic Disease - A Prospective Study from the Czech TULUNG Registry

M. Bratova, B. Karlinova, J. Skrickova, M. Pesek, V. Kolek, L. Koubkova, M. Hrnciarik, J. Krejci, M. Barinova, L. Havel, I. Grygarkova, K. Brat,

. 2020 ; 34 (1) : 369-379. [pub] -

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023280

AIM: To compare survival outcomes in patients with non-small cell lung cancer (NSCLC) treated with modern-era drugs (antifolates, antiangiogenics, tyrosine kinase and anaplastic lymphoma kinase inhibitors, immunotherapy) with treatment initiation in 2011-12 and 2015-16, respectively. PATIENTS AND METHODS: Prospective data from Czech TULUNG Registry (960 patients from 2011-12 and 512 patients from 2015-16) were analyzed. Kaplan-Meier analysis was used to estimate overall survival (OS) and progression-free survival (PFS); Cox proportional hazards model to assess factors associated with 2-year survival. RESULTS: Survival at 2 years was more frequent in cohort 2015-16 compared to cohort 2011-12 (43.2% vs. 24% for adenocarcinoma; p<0.001 and 28.7% vs. 11.8% for squamous-cell lung carcinoma; p=0.002). Assignment to cohort 2015-16 and treatment multilinearity (two or more lines in sequence) were associated with higher probability of 2-year survival (hazard ratio=0.666 and hazard ratio=0.597; p<0.001). Comparison of 2-year survivors from both cohorts showed no differences. CONCLUSION: Survival at 2 years probability in stage IIIB-IV NSCLC doubled between 2011-12 and 2015-16; advanced-stage NSCLC may be considered a chronic disease in a large proportion of patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023280
003      
CZ-PrNML
005      
20201214125638.0
007      
ta
008      
201125s2020 gr f 000 0|eng||
009      
AR
024    7_
$a 10.21873/invivo.11783 $2 doi
035    __
$a (PubMed)31882501
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Bratova, Monika $u Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic. Faculty of Medicine, Masaryk University, Brno, Czech Republic.
245    10
$a Non-small Cell Lung Cancer as a Chronic Disease - A Prospective Study from the Czech TULUNG Registry / $c M. Bratova, B. Karlinova, J. Skrickova, M. Pesek, V. Kolek, L. Koubkova, M. Hrnciarik, J. Krejci, M. Barinova, L. Havel, I. Grygarkova, K. Brat,
520    9_
$a AIM: To compare survival outcomes in patients with non-small cell lung cancer (NSCLC) treated with modern-era drugs (antifolates, antiangiogenics, tyrosine kinase and anaplastic lymphoma kinase inhibitors, immunotherapy) with treatment initiation in 2011-12 and 2015-16, respectively. PATIENTS AND METHODS: Prospective data from Czech TULUNG Registry (960 patients from 2011-12 and 512 patients from 2015-16) were analyzed. Kaplan-Meier analysis was used to estimate overall survival (OS) and progression-free survival (PFS); Cox proportional hazards model to assess factors associated with 2-year survival. RESULTS: Survival at 2 years was more frequent in cohort 2015-16 compared to cohort 2011-12 (43.2% vs. 24% for adenocarcinoma; p<0.001 and 28.7% vs. 11.8% for squamous-cell lung carcinoma; p=0.002). Assignment to cohort 2015-16 and treatment multilinearity (two or more lines in sequence) were associated with higher probability of 2-year survival (hazard ratio=0.666 and hazard ratio=0.597; p<0.001). Comparison of 2-year survivors from both cohorts showed no differences. CONCLUSION: Survival at 2 years probability in stage IIIB-IV NSCLC doubled between 2011-12 and 2015-16; advanced-stage NSCLC may be considered a chronic disease in a large proportion of patients.
650    _2
$a adenokarcinom plic $x epidemiologie $x mortalita $x patologie $x terapie $7 D000077192
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a nemalobuněčný karcinom plic $x epidemiologie $x mortalita $x patologie $x terapie $7 D002289
650    _2
$a spinocelulární karcinom $x epidemiologie $x mortalita $x patologie $x terapie $7 D002294
650    _2
$a chronická nemoc $7 D002908
650    _2
$a kohortové studie $7 D015331
650    _2
$a kombinovaná terapie $7 D003131
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    _2
$a nádory plic $x epidemiologie $x mortalita $x patologie $x terapie $7 D008175
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prognóza $7 D011379
650    _2
$a registrace $x statistika a číselné údaje $7 D012042
650    _2
$a míra přežití $7 D015996
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Karlinova, Bara $u Faculty of Economics and Administration, Masaryk University, Brno, Czech Republic.
700    1_
$a Skrickova, Jana $u Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic. Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Pesek, Milos $u Department of Pneumology, University Hospital Pilsen, Pilsen, Czech Republic. Faculty of Medicine, Charles University in Prague, Pilsen, Czech Republic.
700    1_
$a Kolek, Vitezslav $u Department of Respiratory Medicine, University Hospital Olomouc, Olomouc, Czech Republic. Palacky University, Olomouc, Czech Republic.
700    1_
$a Koubkova, Leona $u Department of Pneumology, University Hospital Motol, Prague, Czech Republic. Second Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Hrnciarik, Michal $u Department of Pneumology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic. Faculty of Medicine, Charles University in Prague, Hradec Kralove, Czech Republic.
700    1_
$a Krejci, Jana $u Department of Pneumology and Thoracic Surgery, Bulovka Hospital, Prague, Czech Republic.
700    1_
$a Barinova, Magda $u Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic.
700    1_
$a Havel, Libor $u Department of Respiratory Medicine, Thomayer Hospital, Prague, Czech Republic.
700    1_
$a Grygarkova, Ivona $u Department of Respiratory Diseases, Prostejov Hospital, Prostejov, Czech Republic.
700    1_
$a Brat, Kristian $u Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic kristian.brat@seznam.cz. Faculty of Medicine, Masaryk University, Brno, Czech Republic.
773    0_
$w MED00175831 $t In vivo $x 1791-7549 $g Roč. 34, č. 1 (2020), s. 369-379
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31882501 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214125637 $b ABA008
999    __
$a ok $b bmc $g 1595599 $s 1113956
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 34 $c 1 $d 369-379 $e - $i 1791-7549 $m In Vivo $n In Vivo $x MED00175831
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace